Tag - Health Intelligence

FDA Alert for Two Neuromuscular Blockade Meds 6-17-20

Executive Summary: The FDA is reportedly sending healthcare providers notice of temporary approval of a missing ‘Paralyzing Agent’ warning from the caps of vials of certain strengths of two neuromuscular blockade IV medications, namely vecuronium bromide and rocuronium bromide.  The affected products, with NDC numbers, manufacturers, and recommendations can be found at the FDA link below.  The missing vial cap warning is important as a safety reminder for a high-risk medication.  More complete details can be found in the body...